Alpha Tau Medical (DRTSW) Stock: Why It's Up Today
Updated Oct 19, 2026, 4:00 PM ET Β· closing price
- Closed at $2.95, +10.07% vs the prior close of $2.68.
- Volume 33.92K shares, 0.8x its 50-day average.
- New SEC filings: 6-K (Oct 19, 2026).
- No new insider buys or sales reported since the prior session.
DRTSW jumps 10.1% to $2.95. Closed at $2.95, +10.07% vs the prior close of $2.68. Day range $2.65β$3.02, opened at $0.33.
DRTSW daily analysis β what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 β DRTSW jumps 10.1% to $2.95
- Closed at $2.95, +10.07% vs the prior close of $2.68. Day range $2.65β$3.02, opened at $0.33.
- Volume was 33.92K shares, 0.8x its 50-day average of 43.37K.
- 52-week range $2.36β$3.02; today's close sits at 89% of that range, 2.3% below the 52-week high.
- SEC filings that day: 6-K.
DRTSW bull case vs bear case (from the data)
- No clear positive signal in the price trend, filings or insider data right now.
- Insider selling outweighs buying: 25 sales vs 0 open-market buys among the 25 most recent reported insider trades (Form 4, last 12 months).
- High volatility: average daily move of 10.1% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
DRTSW latest news & SEC filings
Every SEC filing by or about DRTSW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 19, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 31, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 25, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Levy Raphi sold 2,871 shares at $15.00 (β$43.06K) on Aug 21, 2026
- Levy Raphi sold 2,871 shares at $15.00 (β$43.06K) on Aug 21, 2026
- Levy Raphi sold 2,871 shares at $15.00 (β$43.06K) on Aug 21, 2026
- Levy Raphi sold 2,871 shares at $15.00 (β$43.06K) on Aug 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 21, 2026 Β· Form 144 β Planned insider sale
Notice of proposed sale (Form 144) β an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 12, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Levy Raphi sold 17,730 shares at $14.00 (β$248.22K) on Aug 11, 2026
- Levy Raphi sold 17,730 shares at $14.00 (β$248.22K) on Aug 11, 2026
- Levy Raphi sold 17,730 shares at $14.00 (β$248.22K) on Aug 11, 2026
- Levy Raphi sold 17,730 shares at $14.00 (β$248.22K) on Aug 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 10, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 10, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 21, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 15, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 7, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Levy Raphi sold 2,270 shares at $14.00 (β$31.78K) on Jul 6, 2026
- Levy Raphi sold 2,270 shares at $14.00 (β$31.78K) on Jul 6, 2026
- Levy Raphi sold 2,270 shares at $14.00 (β$31.78K) on Jul 6, 2026
- Levy Raphi sold 2,270 shares at $14.00 (β$31.78K) on Jul 6, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 6, 2026 Β· Form 144 β Planned insider sale
Notice of proposed sale (Form 144) β an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 6, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Levy Raphi sold 17,873 shares at $13.00 (β$232.35K) on Jul 2, 2026
- Levy Raphi sold 17,873 shares at $13.00 (β$232.35K) on Jul 2, 2026
- Levy Raphi sold 17,873 shares at $13.00 (β$232.35K) on Jul 2, 2026
- Levy Raphi sold 17,873 shares at $13.00 (β$232.35K) on Jul 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 25, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jun 23, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Things to know before you trade DRTSW
- How much it moves: over the last 20 sessions the average daily move was 10.07% (largest 10.1%). That is a volatile stock.
- Liquidity: about 38.64K shares (β$114.00K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.95 vs a range of $2.36β$3.02 (89% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Raphi Levy sold 2,871 shares on Aug 21, 2026.
- Latest filings: 6-K Oct 19, 2026; 6-K Aug 31, 2026; 6-K Aug 10, 2026.
- Listing: Nasdaq Β· industry: Surgical & Medical Instruments & Apparatus.
DRTSW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.33 | 3.02 | 2.65 | 2.95 | 33.92K |
| Oct 16, 2026 | 0.33 | 2.97 | 2.36 | 2.68 | 43.37K |
About Alpha Tau Medical
Alpha Tau Medical (DRTSW) is listed on the Nasdaq and classified by the SEC under βSurgical & Medical Instruments & Apparatusβ. Its business address is in JERUSALEM, Israel. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1871321.
DRTSW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Alan Adler | Director | Mar 18, 2026 |
| Ruth Alon | Director | Mar 18, 2026 |
| Michael Avruch | Director | Mar 18, 2026 |
| S Morry Blumenfeld | Director | Mar 18, 2026 |
| Nadav Kidron | Director | Mar 18, 2026 |
| David Mark Milch | Director | Mar 18, 2026 |
| Maya Netser | Director | Mar 18, 2026 |
| Uzi Sofer | Chief Executive Officer | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Raphi Levy | Chief Financial Officer | Aug 25, 2026 |
| Uzi Sofer | Chief Executive Officer | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 21, 2026 | Raphi Levy | Sale | 2,871 | $15.00 |
| Aug 21, 2026 | Raphi Levy | Sale | 2,871 | $15.00 |
| Aug 21, 2026 | Raphi Levy | Sale | 2,871 | $15.00 |
| Aug 21, 2026 | Raphi Levy | Sale | 2,871 | $15.00 |
| Aug 11, 2026 | Raphi Levy | Sale | 17,730 | $14.00 |
| Aug 11, 2026 | Raphi Levy | Sale | 17,730 | $14.00 |
| Aug 11, 2026 | Raphi Levy | Sale | 17,730 | $14.00 |
| Aug 11, 2026 | Raphi Levy | Sale | 17,730 | $14.00 |
| Jul 6, 2026 | Raphi Levy | Sale | 2,270 | $14.00 |
| Jul 6, 2026 | Raphi Levy | Sale | 2,270 | $14.00 |
| Jul 6, 2026 | Raphi Levy | Sale | 2,270 | $14.00 |
| Jul 6, 2026 | Raphi Levy | Sale | 2,270 | $14.00 |
| Jul 2, 2026 | Raphi Levy | Sale | 17,873 | $13.00 |
| Jul 2, 2026 | Raphi Levy | Sale | 17,873 | $13.00 |
| Jul 2, 2026 | Raphi Levy | Sale | 17,873 | $13.00 |
DRTSW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
DRTSW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)MiniMed (MMED)Medline (MDLN)Becton Dickinson (BDX)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on DRTSW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.